EXHIBIT 10.2
To: The Board of eBanker USA.com, Inc.
From: Michael Ruxin, Director, Chairman and CEO; Gordon Segal, Director;
and Gerald Willman, Director, Global Med Technologies, Inc.
Global Med Technologies, Inc. (Global) Hereby Requests the Proposed Terms for a
Loan Extension from eBanker USA.com, Inc. (eBanker)
April 14, 2000
Loan : $2,650,000 loan, convertible into shares of Global at
$1.6875 (market close on 4/14/2000), at 12% interest per
annum, interest and principal due in 270 days following the
date of this agreement. eBanker will have the right to elect
conversion on the due date prior to repayment being
accepted.
Global will provide eBanker with 30-days advance notice
should it choose to repay of the Loan early. In that time
eBanker will have the right to elect for conversion or
repayment.
Commitment Fee : 78,519 free common shares of Global (5% fee, based on a
market price of $1.6875).
Auto Extension : If the Loan's accrued interest or principal is not repaid in
270 days the Loan's interest and principal due date will be
automatically extended to April 15, 2001. The Loan will
become a straight loan, without conversion features.
Interest will continue to accrue on the balance at 12%
interest per annum.
If the Loan's accrued interest or principal is not repaid in
270 days, 10-year warrants convertible into common shares of
Global at an exercise price of $0.50 will be issued to
eBanker. The quantity will be equal to the entire principal
and interest amount divided by the new exercise price.
Underlying : The Global agrees to provide all eBanker-owned common stock
Registration and derivatives on common stock with piggyback registration
rights.
Global commits to completing this registration prior to 180
days follow the date of this agreement.
Global commits to maintain registration of all Global
eBanker-owned common stock and derivatives on common stock.
Confirmation of : Except for the terms above, the terms of the underlying loan
Terms of agreement, including but not limited to the default and
Underlying remedy provisions, shall remain unaffected, unchanged, and
Agreement unimpaired by reason of this amendment
For and on Behalf of:
Global Med Technologies, Inc.
/s/ Michael Ruxin /s/ Gordon Segal
- ----------------------- ----------------------
Michael Ruxin, Director Gordon Segal, Director
Date: April 21, 2000 Date: April 21, 2000
EXHIBIT 10.2 (continued)
/s/ Gerald Willman
- ------------------------
Gerald Willman, Director
Date: April 21, 2000
Agreed and accepted by:
eBanker USA.com, Inc.
/s/ Robert Trapp
- ----------------------
Robert Trapp, Director
Date: April 25, 2000